Measurement of HLA class I expression in ankylosing spondylitis.
AUTOR(ES)
Creamer, P
RESUMO
The importance of HLA-B27 in the pathogenesis of ankylosing spondylitis is uncertain: current evidence favours a role for the B27 molecule itself. The possibility that quantitative differences in HLA-B27 expression may exist between patients with ankylosing spondylitis, family members, and control subjects positive for B27 was examined using appropriate monoclonal antibodies, flow cytometry, and a 'model lymphocyte' coated with a known number of mouse immunoglobulin binding sites. No differences were found between the groups. HLA-A2, examined for comparison, was expressed in greater amounts than HLA-B27, but each contributed only 10-20% of the total class I antigens. Homozygotes expressed twice the amount of antigen expressed by heterozygotes. Synovial lymphocytes expressed more class I antigens than peripheral lymphocytes.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1012419Documentos Relacionados
- Analysis of the MHC class II encoded components of the HLA class I antigen processing pathway in ankylosing spondylitis.
- HLA class II antigens (DR, DQ loci) and peripheral arthritis in ankylosing spondylitis.
- HLA B27, Yersinia enterocolitica, and ankylosing spondylitis.
- HLA B27 and the genetics of ankylosing spondylitis.
- Employment in ankylosing spondylitis.
